-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
226 ，3，201930。，228（+），TOP10，18。
：
，，H+/K+-ATP，、、、-（）。
、、、、，。，2019、、（）30，，，30%；，20%。
13 domestic companies submitted supplementary applications for the consistency evaluation of lansoprazole for injection or reported production under the new classification.
Among them, the products of Shandong Luoxin Pharmaceutical and Osaikang have been successfully evaluated, and the products of Yangzijiang are expected to be the third.
Among them, the products of Shandong Luoxin Pharmaceutical and Osaikang have been successfully evaluated, and the products of Yangzijiang are expected to be the third.
After the conformity evaluation of chemical drug injections was officially launched, the number and speed of over-evaluation of injections have been greatly increased.
According to data from Minai.
com, 228 injections ( counted by drug name + company name) have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangtze River leads with 18 injections.
According to data from Minai.
com, 228 injections ( counted by drug name + company name) have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangtze River leads with 18 injections.
Top 5 companies with the number of over-rated injections
With the increase in the number of over-reviewed products, injections will become the "protagonist" of the national centralized procurement in the future, and Yangtze River's advantage in centralized procurement will be highlighted.
Yangtze River has reviewed injections
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Source: Mi Nei.
com database, announcement of listed companies
com database, announcement of listed companies
Note: The statistics are as of February 24.
If there are any omissions, please correct me!
If there are any omissions, please correct me!
Medical Network News on February 26 A few days ago, Yangzijiang entered the administrative examination and approval stage with the imitation of the 3 types of lansoprazole for injection.
The sales scale of this product in China's public medical institutions in 2019 exceeded 3 billion yuan.
According to data from Meinenet, there are currently 228 injections (in terms of drug name + company name) that have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangzijiang leads with 18 injections.
The sales scale of this product in China's public medical institutions in 2019 exceeded 3 billion yuan.
According to data from Meinenet, there are currently 228 injections (in terms of drug name + company name) that have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangzijiang leads with 18 injections.
Source: official website of the State Food and Drug Administration
Lansoprazole is a proton pump inhibitor, a benzimidazole derivative that can specifically and non-competitively act on H+/K+-ATPase, and is clinically used to treat gastric ulcer and duodenal ulcer , Reflux esophagitis, Zoe-Al syndrome (gastrinoma), etc.
At present, the main dosage forms of lansoprazole commonly used in China are tablets, enteric-coated tablets, capsules, enteric-coated capsules, injections, etc.
Among them, injections are widely used.
According to data from Meinenet, in 2019, the sales of lansoprazole for terminal injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) exceeded 3 billion yuan.
From the perspective of the competitive landscape of manufacturers Shandong Luoxin Pharmaceutical has the highest market share, with more than 30%; followed by Osaikang, with a market share of more than 20%.
Among them, injections are widely used.
According to data from Meinenet, in 2019, the sales of lansoprazole for terminal injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) exceeded 3 billion yuan.
From the perspective of the competitive landscape of manufacturers Shandong Luoxin Pharmaceutical has the highest market share, with more than 30%; followed by Osaikang, with a market share of more than 20%.
13 domestic companies submitted supplementary applications for the consistency evaluation of lansoprazole for injection or reported production under the new classification.
Among them, the products of Shandong Luoxin Pharmaceutical and Osaikang have been successfully evaluated, and the products of Yangzijiang are expected to be the third.
Among them, the products of Shandong Luoxin Pharmaceutical and Osaikang have been successfully evaluated, and the products of Yangzijiang are expected to be the third.
After the conformity evaluation of chemical drug injections was officially launched, the number and speed of over-evaluation of injections have been greatly increased.
According to data from Minai.
com, 228 injections ( counted by drug name + company name) have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangtze River leads with 18 injections.
According to data from Minai.
com, 228 injections ( counted by drug name + company name) have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangtze River leads with 18 injections.
Top 5 companies with the number of over-rated injections
With the increase in the number of over-reviewed products, injections will become the "protagonist" of the national centralized procurement in the future, and Yangtze River's advantage in centralized procurement will be highlighted.
Yangtze River has reviewed injections
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Source: Mi Nei.
com database, announcement of listed companies
com database, announcement of listed companies
Note: The statistics are as of February 24.
If there are any omissions, please correct me!
If there are any omissions, please correct me!
Medical Network News on February 26 A few days ago, Yangzijiang entered the administrative examination and approval stage with the imitation of the 3 types of lansoprazole for injection.
The sales scale of this product in China's public medical institutions in 2019 exceeded 3 billion yuan.
According to data from Meinenet, there are currently 228 injections (in terms of drug name + company name) that have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangzijiang leads with 18 injections.
The sales scale of this product in China's public medical institutions in 2019 exceeded 3 billion yuan.
According to data from Meinenet, there are currently 228 injections (in terms of drug name + company name) that have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangzijiang leads with 18 injections.
Source: official website of the State Food and Drug Administration
Lansoprazole is a proton pump inhibitor, a benzimidazole derivative that can specifically and non-competitively act on H+/K+-ATPase, and is clinically used to treat gastric ulcer and duodenal ulcer , Reflux esophagitis, Zoe-Al syndrome (gastrinoma), etc.
At present, the main dosage forms of lansoprazole commonly used in China are tablets, enteric-coated tablets, capsules, enteric-coated capsules, injections, etc.
Among them, injections are widely used.
According to data from Meinenet, in 2019, the sales of lansoprazole for terminal injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) exceeded 3 billion yuan.
From the perspective of the competitive landscape of manufacturers Shandong Luoxin Pharmaceutical has the highest market share, with more than 30%; followed by Osaikang, with a market share of more than 20%.
Hospital hospital hospitalAmong them, injections are widely used.
According to data from Meinenet, in 2019, the sales of lansoprazole for terminal injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) exceeded 3 billion yuan.
From the perspective of the competitive landscape of manufacturers Shandong Luoxin Pharmaceutical has the highest market share, with more than 30%; followed by Osaikang, with a market share of more than 20%.
13 domestic companies submitted supplementary applications for the consistency evaluation of lansoprazole for injection or reported production under the new classification.
Among them, the products of Shandong Luoxin Pharmaceutical and Osaikang have been successfully evaluated, and the products of Yangzijiang are expected to be the third.
Among them, the products of Shandong Luoxin Pharmaceutical and Osaikang have been successfully evaluated, and the products of Yangzijiang are expected to be the third.
After the conformity evaluation of chemical drug injections was officially launched, the number and speed of over-evaluation of injections have been greatly increased.
According to data from Minai.
com, 228 injections ( counted by drug name + company name) have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangtze River leads with 18 injections.
Drugs Drugs Drugs enterprise business enterpriseAccording to data from Minai.
com, 228 injections ( counted by drug name + company name) have passed or deemed to have passed the consistency evaluation.
Among the TOP10 injection over-evaluated companies, Yangtze River leads with 18 injections.
Top 5 companies with the number of over-rated injections
With the increase in the number of over-reviewed products, injections will become the "protagonist" of the national centralized procurement in the future, and Yangtze River's advantage in centralized procurement will be highlighted.
Yangtze River has reviewed injections
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Source: Mi Nei.
com database, announcement of listed companies
com database, announcement of listed companies
Note: The statistics are as of February 24.
If there are any omissions, please correct me!
If there are any omissions, please correct me!
